Thomas Kerr
Overview
Explore the profile of Thomas Kerr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
704
Citations
15627
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalicum J, Nyx E, Kennedy M, Kerr T
Subst Abuse Treat Prev Policy
. 2025 Mar;
20(1):11.
PMID: 40065329
Background: The Drug User Liberation Front led an evaluation of a non-medicalized model of safer supply known as a "Compassion Club." This club sourced, rigorously tested, packaged, and accurately labeled...
2.
Werb D, Sung H, Na Y, Rammohan I, Eeuwes J, Smoke A, et al.
Lancet Reg Health Am
. 2025 Mar;
43:101022.
PMID: 40027373
Background: Supervised consumption services (SCS) are effective at preventing overdose mortality. However, their effect on public safety remains contested. We investigated homicide rates in areas near SCS in Toronto. Methods:...
3.
Kitchen C, Socias E, Sayre E, Hayashi K, DeBeck K, Milloy M, et al.
Drug Alcohol Rev
. 2025 Feb;
44(3):799-810.
PMID: 40011075
Introduction: Amidst the opioid overdose crisis, there is interest in cannabis use for pain management and harm reduction. We investigated the relationship between cannabis use and cessation of unregulated opioid...
4.
Gallant K, Hayashi K, Sayre E, Choi J, Mansoor M, Kerr T
Subst Abuse Treat Prev Policy
. 2025 Feb;
20(1):9.
PMID: 39987447
Objectives: Canada continues to experience an epidemic of toxic drug-related overdose deaths. Public health messaging emphasizes the dangers of using drugs alone as it restricts timely overdose response or renders...
5.
Stewart A, Hickman M, Agius P, Scott N, Stone J, Roxburgh A, et al.
BMJ Open
. 2025 Feb;
15(2):e091337.
PMID: 39933808
Background: Supervised injecting facilities (SIFs) are designed to reduce the harms associated with injecting drug use and improve access to health and support services for people who need them. The...
6.
Kelsall T, Olding M, Myketiak T, Puri N, Hayashi K, Kerr T, et al.
Discov Public Health
. 2025 Jan;
22(1):20.
PMID: 39845380
Following the onset of the COVID-19 pandemic, an ever-increasing number of people have died from the toxic drug supply in Canada. Emerging evidence suggests that reduced access to harm reduction...
7.
Mitra S, Richardson L, Cui Z, Gilbert M, Milloy M, Hayashi K, et al.
Soc Sci Med
. 2025 Jan;
366:117661.
PMID: 39827688
Background: While marked gender-based differences in drug-related risk and harm between men women who use drugs have been characterized to some extent, the complex relationship between gendered socioeconomic conditions, overdose...
8.
Bowles J, Nyx E, Kalicum J, Kerr T
PLoS One
. 2024 Dec;
19(12):e0315804.
PMID: 39739723
In Canada, the ongoing fatal overdose crisis remains driven by the unpredictable potency and content of the illicit drug supply. From August 2022 until October 2023, the Drug User Liberation...
9.
Cui Z, Karamouzian M, Law M, Hayashi K, Milloy M, Kerr T
Int J Ment Health Addict
. 2024 Dec;
22(6):4004-4020.
PMID: 39722780
Supplementary Information: The online version contains supplementary material available at 10.1007/s11469-023-01098-8.
10.
Lavalley J, Steinhauer L, Bundy D, Kerr T, McNeil R
Int J Drug Policy
. 2024 Nov;
134:104631.
PMID: 39500223
Indigenous Peoples who use illicit drugs (IPWUID) are disproportionately represented among toxic drug poisoning deaths in Canada. These drug-related harms are framed by the historical and ongoing trauma related to...